Literature DB >> 29170876

Venous thromboembolism in assisted reproductive technologies: comparison between unsuccessful versus successful cycles in an Italian cohort.

Michela Villani1, Giovanni Favuzzi1, Pasquale Totaro2, Elena Chinni1, Gennaro Vecchione1, Patrizia Vergura1, Lucia Fischetti1, Maurizio Margaglione3, Elvira Grandone4.   

Abstract

Pregnancies after assisted reproductive technologies (ART) have been associated with an increased risk of venous thromboembolism (VTE). On the contrary, the magnitude of this risk in unsuccessful ART cycles (not resulting in a clinical pregnancy) has not yet been clearly defined. In this study, we evaluated the incidence of VTE in unsuccessful cycles and compared it with that recorded in successful cycles in the same study population. From a cohort of 998 women consecutively referred by local Fertility Clinics to our Atherosclerosis and Thrombosis Unit (April 2002-July 2011), we identified and included women with at least one cycle of ovarian stimulation and a negative history for VTE. Overall, 661 women undergone 1518 unsuccessful and 318 successful cycles of ovarian stimulation, respectively, were analysed. VTE events occurred in 2/1518 (1.3‰) unsuccessful cycles compared with 3/318 (9.4‰) successful cycles, (Two-tailed Fisher exact test, p = 0.04, OR 0.14, 95% CI 0.02-1.02). Both cases observed in unsuccessful cycles were isolated pulmonary embolism occurred after OHSS; no antithrombotic prophylaxis had been prescribed. At logistic regression analysis, the occurrence of successful cycle and BMI were significantly and independently associated with the occurrence of VTE with an OR of 13.94 (95% CI 1.41-137.45) and 1.23 (95% CI 1.01-1.49), respectively. VTE incidence is significantly lower in unsuccessful cycles as compared to that of successful ones. However, although rare, thrombotic risk during ovarian stimulation cannot be excluded and, when it occurs, can be life-threatening. Therefore, particular attention should be paid to these women, independently of ART outcome.

Entities:  

Keywords:  Assisted reproductive techniques; Heparin; Ovarian hyperstimulation syndrome; Risk factors; Venous thromboembolism

Mesh:

Year:  2018        PMID: 29170876     DOI: 10.1007/s11239-017-1584-z

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  14 in total

1.  Lower birth-weight in neonates of mothers carrying factor V G1691A and factor II A(20210) mutations.

Authors:  Elvira Grandone; Maurizio Margaglione; Donatella Colaizzo; Giuseppe Pavone; Dario Paladini; Pasquale Martinelli; Giovanni Di Minno
Journal:  Haematologica       Date:  2002-02       Impact factor: 9.941

2.  VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Shannon M Bates; Ian A Greer; Saskia Middeldorp; David L Veenstra; Anne-Marie Prabulos; Per Olav Vandvik
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Artificial reproductive technology and the risk of venous thromboembolic disease.

Authors:  S M Nelson; I A Greer
Journal:  J Thromb Haemost       Date:  2006-08       Impact factor: 5.824

4.  Incidence and risk patterns of venous thromboembolism in pregnancy and puerperium--a register-based case-control study.

Authors:  Anne Flem Jacobsen; Finn Egil Skjeldestad; Per Morten Sandset
Journal:  Am J Obstet Gynecol       Date:  2007-11-12       Impact factor: 8.661

5.  International Committee for Monitoring Assisted Reproductive Technology (ICMART) and the World Health Organization (WHO) revised glossary of ART terminology, 2009.

Authors:  F Zegers-Hochschild; G D Adamson; J de Mouzon; O Ishihara; R Mansour; K Nygren; E Sullivan; S Vanderpoel
Journal:  Fertil Steril       Date:  2009-10-14       Impact factor: 7.329

6.  No evidence that assisted reproduction increases the risk of thrombosis: a Danish national cohort study.

Authors:  A T Hansen; U S Kesmodel; S Juul; A M Hvas
Journal:  Hum Reprod       Date:  2012-02-21       Impact factor: 6.918

Review 7.  Symposium: Update on prediction and management of OHSS. Epidemiology of OHSS.

Authors:  Annick Delvigne
Journal:  Reprod Biomed Online       Date:  2009-07       Impact factor: 3.828

8.  Age and homocysteine plasma levels are risk factors for thrombotic complications after ovarian stimulation.

Authors:  E Grandone; D Colaizzo; P Vergura; F Cappucci; G Vecchione; A Lo Bue; E Cittadini; M Margaglione
Journal:  Hum Reprod       Date:  2004-06-03       Impact factor: 6.918

9.  Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study.

Authors:  Peter Henriksson; Eli Westerlund; Håkan Wallén; Lena Brandt; Outi Hovatta; Anders Ekbom
Journal:  BMJ       Date:  2013-01-15

10.  Pregnancy-related venous thrombosis: comparison between spontaneous and ART conception in an Italian cohort.

Authors:  Michela Villani; Francesco Dentali; Donatella Colaizzo; Giovanni Luca Tiscia; Patrizia Vergura; Tiziana Petruccelli; Francesco Petruzzelli; Walter Ageno; Maurizio Margaglione; Elvira Grandone
Journal:  BMJ Open       Date:  2015-10-06       Impact factor: 2.692

View more
  1 in total

Review 1.  Is thromboprophylaxis cost effective in ovarian hyperstimulation syndrome: A systematic review and cost analysis.

Authors:  Kelly Comerford Wormer; Ayesha A Jangda; Farah A El Sayed; Katherine I Stewart; Sunni L Mumford; James H Segars
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2018-03-19       Impact factor: 2.435

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.